Wissenschaftliches Programm Scientific Program Dienstag, 19. Februar 2013 | Tuesday, February 19, 2013 07:30 – 08:30 Tagungsraum 1 Seite 80 Seite 131 07:30 – 08:30 Tagungsraum 2 Seite 131 08:30 – 10:00 Plenum www.dgthg-jahrestagung.de <strong>Hand</strong> auf´s <strong>Herz</strong> <strong>Hand</strong> on Heart Sharing Best Practice and Experiences in Transvenous Lead Extraction supported by Spectranetics Deutschland GmbH HeartWare Update and Perspectives for the Future supported by HeartWare International, Inc. Main Session Diffcult Decisions Inside the Heart Team Joint Session DGK & DGTHG Chair: C. Hamm (Bad Nauheim) F.W. Mohr (Leipzig) Case presentation, discussion and clinical solution H. Treede (Hamburg) Case presentation, discussion and clinical solution H.-J. Büttner (Bad Krotzingen) Case presentation, discussion and clinical solution H. Möllmann (Bad Nauheim) Discussion C.K. Naber (Essen) J. Gummert (Bad Oeynhausen)
Dienstag, 19. Februar 2013 | Tuesday, February 19, 2013 08:30 – 10:00 Tagungsraum 1 Oral Presentation Heart Failure – Organ Transplantation Chair: A. Haverich (Hannover) H. Reichenspurner (Hamburg) Wissenschaftliches Programm Scientific Program OP127 Additional intraoperative blood cardioplegia to improve donor heart ischemic tolerance – a single center prospective cohort study F.M. Wagner, I. Subbotina, T. Deuse, P. Marcsek, H. Treede, M. Kubik, K. Müllerleile, H. Reichenspurner (Hamburg) OP128 Cardiac accumulation of a human recombinant antibody recognizing ED-A+ fibronectin after heterotopic rat heart transplantation in vivo: A new strategy to detect and treat chronic cardiac allograft rejection? M. Franz, I. Hilger, D. Neri, K. Grün, S. Kossatz, J. Gummert, H.R. Figulla, A. Berndt, A. Renner (Jena, Zürich, Bad Oeynhausen) OP129 Non-stenotic coronary vasculopathy is associated with reduced survival after heart transplantation N.E. Hiemann, E. Wellnhofer, C. Christan, S. Kretschmer, R. Meyer, H. Valantine, R. Hetzer, K.K. Khush (Berlin, Stanford) OP130 Does mechanical circulatory support prior to heart transplantation influence early onset of coronary allograft vasculopathy? H.A. Welp, A. Osterhues, J. Stypmann, A. Hoffmeier, H.H. Scheld, S. Martens, J. Sindermann (Münster) OP131 It’s not the bad guys. A differentiated view on post HTX adherence: Medication, mental health, hygienic behavior K. Tigges-Limmer, Y. Brocks, D. Grisse, A. Zittermann, G. Schmid-Ott, U. Schulz, J. Brakhage, A. Benkler, J. Gummert (Bad Oeynhausen, Löhne) OP132 Gender matched homograft tissues yield better survival after surgery P. Roth, B. Niemann, M. Budak, J. Wilhelm, A. Böning (Giessen) OP133 Cardiac death does not preclude potential donors from heart transplantation S. Li, S. Loganathan, S. Korkmaz, E. Barnucz, T. Radovits, A. Weymann, S. Páli, P. Hegedüs, K. Hirschberg, M. Karck, G. Szabó (Heidelberg, Wu Han, Budapest) OP134 Mitral valve surgery after orthotopic heart transplantation – an effective and safe treatment option N. Reiss, M. Fritz, M. Karck, A. Ruhparwar (Heidelberg) OP135 Tumor incidence in heart transplant recipients receiving cyclosporin A or tacrolimus as maintenance therapy U. Fuchs, A. Zittermann, S. Klein, S. Ensminger, U. Schulz, J.F. Gummert (Bad Oeynhausen) www.dgthg-jahrestagung.de Page 81 Dienstag Tuesday